Novel Personalized Cellular Therapy Approach for Immune Diseases

Project description

Innovative cell therapy for inflammatory bowel diseases

Fields of science

• social sciences › economics and business › economics › health economics › economic impact of epidemics

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

TLA TARGETED IMMUNOTHERAPIES AB

Net EU contribution

€ 2 695 000,00

Address

Ekonomilanken Ab Box 726
191 27 Sollentuna
Sweden

Region

Östra Sverige › Stockholm › Stockholms län

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 1 155 000,00